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Purpose: The aim of this project was to evaluate the feasibility of aortoscopy for guidance 
of endoluminal aortic procedures and to determine whether aortoscopy has advantages 
over fluoroscopy in a pig model. 
Methods: To establish feasibility aortoscopic guidance was used for making endoluminal 
aortic measurements, cannulating small arteries for arteriograpy, and placing intraaortic 
stents and grafts in 11 pigs. To compare aortoscopy and fluoroscopy measurements were 
made and stents were placed by a surgeon using only aortoscopic guidance in 10 pigs and 
by an interventional radiologist using only fluoroscopic guidance in 10 pigs. Postmortem 
dissections were performed to determine measurement and device placement accuracy. 
Results: In the feasibility study aortoscopic measurements differed from postmortem 
measurements by a mean distance (+SD) of 1.2 + 0.2 nun. Stents and grafts were placed a
mean of 2.3 + 1.9 mm distal to the most inferior renal artery with no stent covering an 
orifice. All attempts at cannulating spinal arteries greater than 2 mm in diameter were 
successful. In the comparison of aortoscopic and fluoroscopic guidance, fluoroscopic 
measurements differed from postmortem measurements by 2.6 _+ 2.4 mm (p = 0.223). 
Stents placed with aortoscopic guidance were 1.1 + 1.3 mm distal to the most inferior enal 
artery, whereas tents placed with fluoroscopic guidance were 3.4 + 2.5 mm distal to the 
most inferior enal artery (p = 0.019). 
Conclusions: These resnlts demonstrate hat aortoscopy is a usehtl guidance system for
endoluminal ortic procedures and may have advantages over fluoroscopy alone. (J Vase 
Surg 1996;24:439-48.) 
Recent advances in catheter-based technology 
have made possible a variety of minimally invasive 
approaches for the treatment of aortic aneurysmal nd 
occlusive disease. Long-term results are becoming 
available for endoluminal aortic aneurysm exclusion, 
and the complications most commonly reported are 
leakage from incomplete xclusion, which has caused 
aneurysm rupture and death, and inability to properly 
position the deployed graft. 1-~ Endoluminal aortic 
aneurysm exclusion requires an adequate proximal 
aneurysm neck for fixation of the endoluminal graft. 6 
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The adequacy of the proximal aneurysm neck de- 
pends in part on the accuracy with which the endolu- 
minal graft can be positioned and used. The accuracy 
of endoluminal graft deployment in turn depends on 
the information provided by the guidance system that 
is used during the procedure, preoperative computed 
tomographic measurements, and sometimes intraop- 
erative assessment with fluoroscopic and intravascular 
ultrasonography techniques. 
Guidance systems for endovascular surgery in- 
clude fluoroscopy, intravascular ultrasonography, and 
angioscopy. Until recently aortic angioscopy was 
precluded by high blood flow and the inability to clear 
the visual field without infusing an unacceptably large 
volume of  fluid. The evolution of  aortoscopic tech- 
nology has involved investigations in several different 
areas of cardiovascular research. The development of
unique angioscopic equipment has required modifi- 
cation of existing devices at each stage. In 1967 
Gamble and Innis 7 reported the use of a balloon- 
tipped catheter o visualize the chambers of the heart 
and great vessels. Angioscopic inspection of pulmo- 
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nary arteries with a balloon angioscope was described 
by Shure et al. 8 in 1985. Later, Kuo and Koch  9 used a 
balloon angioscope to assist in electrophysiologic 
studies that required attaching endocardial e ectrodes 
at specific locations in the beating heart of a dog. The 
first reported use of the aortoscope for endoluminal 
aortic inspection and guidance ofstent placement in a 
pig model was reported by Buckmaster et al. 1° in 
1995. The first clinical use of aortoscopy was also 
reported by our group in 1995 and involved the 
inspection of a Parodi-type ndoluminal aortic graft 
that had been placed 1 year earlier to exclude an 
abdominal aortic ancurysm, n 
We designed a series of experiments o establish 
the feasibility ofaortoscopy and to define its potential 
role as a guidance system for cndovascular surgery. 
Our hypothesis was that aortoscopy can be used to 
provide visual guidance for intraoperative aortic 
length measurements to assist in graft preparation, 
cannulation of  small branching arteries for arteriog- 
raphy, and use of intraaortic devices. We also per- 
formed experiments ocompare aortoscopy and fluo- 
roscopy as guidance systems for endoluminal mea- 
surements and stent use in the pig aorta. In all 
experiments only linear endoluminal distances were 
measured, not aortic diameters. 
MATERIAL  AND METHODS 
Device description. The aortoscope assembly 
consists of a 1.9 mm Intramed (Baxter Healthcarc 
Corp., Intramed Laboratories, San Diego, Calif.) 
angioscope and an investigational catheter with a 
balloon bonded to one end. The angioscope is intro- 
duced into the catheter through a one-way valve and 
is advanced until the lens of the angioscopc is inside 
the balloon (Fig. 1). The balloon is insufflated with 
sterile saline solution or a radioopaque contrast ma- 
terial that is injected through the worldng channel of 
the angioscope. A fluid volume of 14 cc will expand 
the balloon to a diameter of 28 mm. The one-way 
valve is necessary to prevent leakage of the clear 
solution out of the balloon through the space be- 
tween the wall of the balloon catheter and the 
endoscope. The angioscope is connected to a stan- 
dard 300-W halogen light source and a video camera 
for imaging. 
The entire aortoscope assembly issmall enough to 
pass through a9F introducer sheath that is placed into 
the pig carotid artery by a cutdown technique. The 
introducer is 40-cm long and is introduced over a 
guidewire into the descending thoracic aorta. Once 
the aortoscope is positioned in the abdominal aorta, 
the balloon is insufflated until it occludes aortic blood 
flow. When this occurs the transparent balloon and 
aortic intima make circumferential contact, thereby 
allowing a 360-degree view of the aortic cndoluminal 
surface. Advancing and withdrawing the aortoscope 
allows the surgeon to map out the endoluminal 
surface, make measurements with the aid of an 
endoluminal catheter as described in the following 
text, and guide the placement of devices in the aorta. 
Because the aortoscope is introduced from proxi- 
mal to distal, the aortoscope camera head is rotated so 
that the orientation on the video monitor corre- 
sponds to the orientation of the aortoscope in the 
subject. To obtain the correct camera orientation a
small air bubble is injected into the aortoscope 
balloon. Because the air bubble will float anteriorly in 
a supine patient, the camera is rotated so that the air 
bubble is at the 12 o'clock position on the video 
monitor view. This procedure will ensure that what is 
seen on the right side of  the video monitor, or the 
3 o'clock position, is on the right side of the subject's 
aorta. The 12 o'clock position on the video monitor 
is anterior in the subject's aorta, and the 6 o'clock 
position on the monitor is posterior in the subject's 
aorta. 
Because only what is in contact with the aorto- 
scope balloon can be seen, the blood-balloon inter- 
face at a branching artery orifice appears as a red spot 
against the pale color of the surrounding aortic intima 
(Fig. 2). 
Feasibi l i~ study. An initial study was performed 
to determine the utility of aortoscopy for measuring 
aortic length. All procedures complied with the 
"Principles of Laboratory Animal Care" and the 
Guide for the Care and Use of Laboratory Animals 
(NIH Publication No. 86-23, revised 1985). Eleven 
pigs, each weighing 50 to 70 kg, were sedated with 
ketamine. General anesthesia was induced and main- 
tained with isofluorane. A jugular vein was isolated for 
fluid and drug administration, and a carotid artery 
and both common femoral arteries were exposed for 
cannulation. Intravenous hepatin (100 U/kg)  was 
administered for anticoagulation. 
The aortoscope was introduced into the descend- 
ing thoracic aorta through acarotid arteriotomy. The 
aortoscope balloon was insufflated with sterile saline 
solution and advanced until the aortic trifurcation, 
consisting of right and left common iliac arteries and 
the middle sacral artery, became visible. The balloon 
was deflated before the aortoscope was moved, an 
important maneuver in the clinical setting to decrease 
the risk of injury to the aortic wall and dislodgment of  
thrombotic or atheromatous material. The aorto- 
scope was slowly withdrawn proximally so that the 
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Fig. 1. Aortoscope assembly consists of 1.9 mm Intramed angioscope inserted through 9F 
balloon-tipped catheter; balloon insufflated with clear solution by way of 0.6 mm working 
channel. 
positions of the renal and visceral arteries could be 
determined. The initial inspection helped to create a 
mental "road map" of the endoluminal ortic surface. 
Indirect endoluminal measurements weremade in 
all pigs with a prototype nondirectional 5F millime- 
ter-ruled catheter that was introduced into the aorta 
through a femoral introducer sheath. The aortic 
length from the most inferior renal artery orifice to 
the aortic trifurcation was measured. The aortoscope 
was positioned so that the inferior edge of the most 
inferior renal artery orifice was in clear view. The 
endoluminal measuring catheter was advanced 
through the femoral introducer sheath proximally in 
the aorta until the tip of the catheter touched the 
aortoscope balloon exactly at the inferior edge of the 
renal artery orifice. The catheter position at the 
introducer site was recorded in millimeters as R (Fig. 
3). The catheter was withdrawn distally 12 to 15 cm. 
The aortoscope was advanced until the aortic trifur- 
cation became visible. The endoluminal measuring 
catheter was then advanced until the tip of the 
catheter touched the aortoscope balloon at the level 
of the aortic trifurcation. The measuring catheter 
position was recorded in millimeters as T. The inffa- 
renal total aortic length (TAL) was determined by the 
formula TAL = T -  R. The TAL recorded for each 
experiment represented th  average of three consecu- 
tive measurements. 
In 4 ,of these initial 11 pigs, selective spinal artery 
cannulation with only aortoscopic guidance was per- 
formed. A straight 5F single-lumen catheter was used. 
The arterial orifice of interest was covered by the 
aortoscope balloon such that the inferior edge of the 
Fig. 2. Digitized image ofendoluminal pig aorta looldng 
distally through aortoscope; large arrow shows right renal 
artery orifice; smal l  arrow shows left renal artery orifice 
cannulated with angiogram catheter f om femoral artery; 
bright spot in center is light reflecting offinside surface of 
aortoscope balloon; branching arteries and distal aortic 
lumen appear as red spots against pale color of aortic intima. 
(Resolution of image in photograph limited by lack of color 
and absence of consecutive r al-time video images.) 
orifice was in contact with the column of blood in 
aortic lumen di'stal to the balloon. The catheter was 
advanced proximally through a femoral introducer 
until the tip of the catheter touched the aortoscope 
balloon. The catheter was turned or rotated so that it 
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right renal 
Total Aortic 
Length 
L 
left renal artery 
stent 
inferior mesenteric arter.y 
•-•R Device Placement Error 
right c. iliac arter'y---~,~ v / |  ~- - - - - - - l e f f  c. iliac artery 
middle sacral artery 
Fig. 3. Diagram depicts endoluminal distances measured. 
R, Renal (inferior edge of most inferior enal artery orifice); 
T, trifurcation; D, device (proximal end ofstent or graft); 
TAL is distance from inferior edge of most inferior enal 
artery orifice to distal aortic trifurcation; TAL = T -  114 
Device Placement Error is distance from inferior edge of 
most inferior enal artery orifice to proximal edge ofstent or 
graft; DPE = D - R. 
rolled in the narrow space between the balloon and 
the aortic intima. Clockwise rotation of the catheter 
around the inside surface of the aorta was seen as 
counterclockwise rotation on the video monitor. 
When the tip of the catheter was positioned irectly at 
the inferior edge of the arterial orifice of interest, the 
catheter was advanced proximally until it was de- 
flected into the arterial orifice by the aortoscope 
balloon. 
Aortoscopic guidance was used to position and 
place Palmaz stents in seven pigs. Before a device was 
placed in the aorta, the most inferior enal artery was 
identified with aortoscopy. A Palmaz stent (P308; 
Johnson and Johnson Interventional Systems Co., 
Warren, N.J.) 30 mm in length and 3.1 mm in 
diameter, designed for expansion to 12 mm, was 
crimped onto a 9F angioplasty catheter (Medi-tech 
DC/12-3 /9 /100;  Boston Scientific, Watertown, 
Mass.) that had a 12 mm x 3 cm balloon. The catheter 
and loaded stent were introduced into a common 
femoral artery. With only aortoscopic guidance the 
leading edge of the stent was aligned precisely with 
the inferior edge of  the most inferior renal artery 
orifice. During its actual expansion aortoscopic visu- 
alization of the stent was not possible because of the 
"fighting balloons" problem illustrated in Fig. 4. 
After expansion the stent was inspected with aortos- 
copy, and its position was noted in relation to the renal 
arteries. 
Placement of expandable polytetrafluoroethylene 
stent grafts in the infrarenal aorta was attempted in 
four pigs. The unexpandcd 3 mm x 9 cm polytet- 
rafluoroethylene grafts (Endomcd Incorporated, 
Phoenix, Ariz.) with internal Palmaz P308 stents for 
fixation were crimped onto a 9F angioplasty catheter 
(Olbert Catheter System Cat. No. 700745; Meadox 
Surgimed, Oaldand, N. J.) that had a 14 mmx 4 cm 
balloon. The stent graft was positioned at the inferior 
edge of the most inferior enal artery orifice with the 
described technique for stent placement. The stent 
graft was used by inflating the angioplasty balloon to 
a pressure of 9 arm. The stent graft was inspected with 
aortoscopy, and its position was noted in relation to 
the renal arteries. In one pig rupture of the balloon 
prevented placement of the stent graft. 
After the devices were placed, cardiac arrest was 
induced with a saturated potassium chloride solution, 
and postmortem dissections were performed to ex- 
pose the abdominal aorta so that direct measurements 
could be made (Fig. 4). Measurements of TAL from 
the inferior edge of  the most inferior renal artery to 
the aortic trifurcation were recorded, as were mea- 
surements of stent placement error from the inferior 
renal artery orifice to the proximal end of the device 
that was placed with aortoscopic guidance. Care was 
taken to prevent displacement of the stcnts and stent 
grafts during dissection. In some of the initial experi- 
ments that were conducted before this study, aortic 
diameter and length were measured in live animals 
with normal hemodynamic parameters and were then 
measured again after death. Although aortic diameter 
decreased significantly after death, aortic length from 
the most inferior enal artery to the aortic trifurcation 
remained constant as long as the aorta was not 
transected, presumably because of  retroperitoneal 
and iliac attachments proximally and distally. Because 
of  this observation and the fact that only linear 
measurements were needed for this study, all direct 
open measurements were made after death. 
Prospective comparison of aortoscopic and 
fluoroscopic endoluminal measurements and ac- 
curacy o f  intraaortic stent placement. Twenty pigs 
were divided into two groups. In 10 pigs in group A 
an interventional radiologist used fluoroscopic guid- 
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Fig. 4. Postmortem dissection of pig shows position of 
Palmaz stent (P308) used in abdominal aorta with aorto- 
scopic guidance only; proximal end ofstent aligned exactly 
with inferior edge of most inferior enal artery orifice. 
ance and an endoluminal measuring catheter to mea- 
sure the aortic length from the most inferior renal 
artery orifice to the distal aortic trifurcation. This 
procedure was done by keeping the measuring cath- 
eter tip in the center of the fluoroscopy field to 
minimize parallax, selectively cannulating the most 
inferior renal artery orifice, and recording the mea- 
suring catheter position at the femoral artery intro- 
ducer site as R (Fig. 3). The measuring catheter was 
withdrawn distally until its tip was at the level of the 
aortic trifurcation, and the catheter position at the 
introducer site was recorded as T. Infrarenal aortic 
length (L) was calculated by the formula TAL = 
T - R. The TAL recorded for each experiment repre- 
sented the average of three consecutive measure- 
ments. Standard fluoroscopic techniques with exter- 
nal markers as landmarks were used to position and 
expand aPalmaz P308 stent. In 10 pigs in group B a 
surgeon used aortoscopic guidance and an endolumi- 
lO , l 0 . 
Fig. 5. Problem with "fighting balloons" depicted; ta- 
pered tip of deployment balloon interferes with aortoscopic 
view of proximal graft edge during graft expansion. 
nal measuring catheter introduced by way of a com- 
mon femoral artery to measure the aortic length from 
the most inferior enal artery orifice to the distal aortic 
trifurcation. "Fighting balloons" prevented visualiza- 
tion of the Palmaz P308 stent briefly during its actual 
expansion after it was positioned with fluoroscopic 
guidance. In both procedures the goal was to place 
the superior edge of the stent as close as possible to the 
inferior edge of the most inferior renal artery orifice 
without covering or occluding the orifice. 
In all pigs in groups A and B, after stents were 
placed, cardiac arrest was induced and laparotomies 
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were performed to allow direct measurement of the 
aortic length and the distance from the inferior edge 
of the most inferior enal artery orifice to the proximal 
edge of the stent as described. 
Comparative statistical analysis of  results was per- 
formed with the t test for independent samples, 
analysis of variance. 
Aortoscopic guidance o f  corvita endoluminal 
graft placement. In five pigs aortoscopic guidance 
was used to measure aortic length and to position and 
place self-expanding Corvita endoluminal grafts 
(MIA CEG-50728A3-14 mm; Corvita Corporation, 
Miami, Fla.) 14 mm in diameter when fully expanded. 
After aortic length was determined with aortoscopic 
guidance as described, the Corvita graft was cut to a 
length 5 mm shorter than the measured aortic length 
with heavy scissors and was loaded into a 1 OF Corvita 
Delivery Set (Cordis special products cat. no. 
520000M-16102; Cordis Corporation). Before the 
device was placed in the aorta, the most inferior enal 
artery was identified with aortoscopy. The deploy- 
ment catheter was introduced into the common 
femoral artery through an introducer sheath and was 
advanced until the proximal edge of  the deployment 
catheter touched the aortoscope balloon. With the 
proximal end of the deployment catheter positioned 
at the inferior edge of the most inferior renal artery 
orifice, the self-expanding graft was slowly deployed 
by pulling the deployment sheath distally with a 
"pusher catheter" present within the sheath to main- 
tain position of the graft. As the graft expanded, 
aortoscopic guidance was used to maintain alignment 
of the proximal graft end with the inferior edge of the 
renal artery orifice. Full deployment was complete 
when the deployment sheath ad been pulled back 12 
cm and the proximal graft edge was determined with 
aortoscopy to be fully expanded against he circum- 
ference of the endoluminal orta. The aortoscope was 
used to inspect he inside of  the graft and to verify the 
patency of the common iliac orifices. 
After device deployment and aortoscopic inspec- 
tion were performed, cardiac arrest was induced, and 
laparotomies were performed on all animals to allow 
direct measurement of the aortic length and the 
distance from the inferior edge of the most inferior 
renal artery orifice to the proximal edge of the stent as 
described. A summary of the overall study design is 
presented in Table I. 
RESULTS 
Feasibility study. In the initial feasibility study 
the "true" TAL and device placement error (DPE) 
were determined by postmortem dissection as de- 
scribed in Fig. 3. The aortoscopic measurement error 
(ME) was determined by subtracting the "true" TAL 
measurement from the "aortoscopic" TAL measure- 
ment: MEaort . . . .  py"~ TALaort . . . .  py - TAL=u e. The 
mean aortoscopic measurement error (±SD) was 
1.2 + 0.6 mm, where n = 11. 
In the four pigs in the cannulation group, all 
arterial orifices that were distal to the superior mesen- 
teric artery and that had diameters equal to or greater 
than the arteriography catheter (5F, 1.6 ram) under- 
went successful cannulation, each cannulation gener- 
ally requiring less than 60 seconds to perform. 
Mean DPE (±SD) was 2.3 + 3.1 ram, where 
n = 10. No stent or graft occluded or partially covered 
a renal artery orifice. 
Prospective comparison o f  aortoscopic and 
fluoroscopic endoluminal measurements and ac- 
curacy  of  intraaortic stent placement. Fluoro- 
scopic, aortoscopic, and direct postmortem easure- 
ments ofinfrarenal TAL were made as described, and 
the results are listed in Table II. A fluoroscopic or 
aortoscopic measurement that was shorter than the 
"true" postmortem measurement was assigned a 
negative value, a measurement that was longer than 
the "true" measurement was assigned a positive 
value, and a perfect measurement was assigned a value 
of zero. Mean ME n . . . .  scopy (±SD) in group A was 
3.8 ±2.4 mm, whereas mean MEaort . . . .  py was 
2 .6±2.4  mm in group B (p=0.223) .  Mean 
MEn . . . . . . .  py and mean MEaorr . . . .  py were calculated 
with the absolute values of individual measurement 
errors: ME = [~/(MEi) 2 + ~/(ME22 + . . .  + 
"](MEn)2]/n, where n = total number of individual 
measurement errors. 
For each pig DPE was determined by postmortem 
dissection as shown in Fig. 3, and the results are listed 
in Table III. A stent that was placed inferior to the 
renal artery orifice was assigned a positive value, a 
stent placed on top of  a renal artery was assigned a
negative value, and a perfectly placed stent was 
assigned a value of zero. Mean DPEa . . . . . . .  py was 
3.4 ± 2.5 mm in group A, whereas DPEaor~ . . . .  py was 
1.1 ± 1.3 mm in group B (p = 0.019). Partial cover- 
ing of the most inferior renal artery orifice with a 
stent, 2 mm in each case, occurred in one pig in group 
A and one pig in group B. Mean DPE~ . . . . . . .  py and 
mean DPEao~t . . . .  py were calculated with the absolute 
values of individual device placement errors: 
DPE = [~(DPE1) 2+ ~/(DPE2) 2+. . .  + ~/(DPEn)2]/n, 
where n = total number of individual device place- 
ment errors. 
Corvita endoluminal graft placement with aor- 
toscopic guidance. In the five pigs the mean 
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Tab le  I .  Aortoscopy study design 
Feasibility study (n = 11 pigs): 
Palmaz stent group (n = 7 pigs) 
7 of 7 had endoluminal measurements 
7 of 7 had infrarenal Palmaz P308 stent placement with aortoscopic guidance 
4 of 7 had spinal artery catheterization with aortoscopic guidance 
Polytetrafluoroethylene stent graft group (n = 4 pigs) 
4 of 4 had endoluminal ortoscopic measurements 
3 of 4 had infrarenal polytetrafluoroethylene stent graft placement with aortoscopic guidance 
1 of 4 had deployment balloon rupture that precluded stent graft placement 
Prospective comparison of aortoscopy and fluoroscopy (n = 20 pigs): 
Fluoroscopy group (Group A; n = 10 pigs) 
9 of 10 had endoluminal fluoroscopic measurements 
10 of 10 had infrarenal Palmaz P308 stent placement with only fluoroscopic guidance 
Aortoscopy group (Group B; n = 10 pigs )
10 of 10 had endoluminal ortoscopic measurements 
10 of 10 had infrarenal Palmaz P308 stent placement with only aortoscopic guidance 
Use of Corvita endoluminal grafts with aortoscopic guidance (n = 5 pigs): 
5 of 5 had endoluminal ortoscopic measurements 
5 of 5 had infrarenal Corvita endoluminal graft placement with aortoscopic guidance 
Tab le  I I .  Prospective comparison of  f luoroscopic and aortoscopic guidance for endoluminal  
aortic measurements 
Fluoroscopic measurement (ram) (group A; n = 9pigs) Aortoscopic measurement (ram) (group B; n = lO pigs) 
TALfluoroscopy TAL~,~ MEf .  ...... py TAL,~o~to~opy TALt~ ME.~o~to~co~,y 
- -  - -  - -  99 100 - 1  
108 108 0 99 99 0 
89 94 -5 97 98 -1 
123 126 -3 92 97 -5 
103 106 -3 108 112 -4 
95 102 -7 67 70 -3 
81 84 -3 103 107 -4 
102 95 +7 111 114 -3 
104 105 -1 92 89 +3 
90 95 -5 97 99 -2 
Mean fluoroscopic measurement error 3.8 _+ 2.4 mm 
Mean aortoscopic measurement error 2.6 -+ 2.4 mm 
@ = 0.223) 
TAL, Total aortic length measurement as depicted in Fig. 3; ME, measurement error (ME n . . . . . . .  py = TAtfluoroscopy-TAL~u¢; 
MEaortoscopy = TAgaortoscopy -- TALt.ue ). 
MEaort . . . .  py (±SD) was 2.4 + 1.1 mm. The 
DPEaort . . . .  py was 1.4 _+ 1.9 mm. The actual distances 
in mil l imeters from the inferior edge o f  the lowest 
renal artery orifice to the proximal end of  the Corvita 
graft were -3 ,  0, 0, 0, and --4. No  graft occluded or 
partially covered a renal artery orifice or a common 
iliac artery orifice distally. In two of  the five cases a 9F 
angioplasty catheter (Medi-tech,  Inc., Watertown,  
Mass.) was required to fully expand the proximal end 
of  the graft. 
D ISCUSSION 
This study demonstrates that aortoscopy can be 
used to make accurate endoluminal  measurements,  
guide the deployment  ofstents  and grafts, and direct 
the cannulation o f  spinal arteries. The results also 
suggest hat aortoscopic guidance is as accurate as 
f luoroscopy when aortic cndoluminal  distances are 
measured and more accurate than f luoroscopy when 
stents are placed adjacent o the most  inferior renal 
artery in the pig aorta. In humans the applicabil ity of  
aortoscopic guidance for endoluminal  procedures has 
not  been established, and diseased vessels may make 
the technique more difficult to perform. 
F luoroscopy is the pr imary guidance modal i ty 
used today, but  it provides l imited endoluminal  infor- 
mat ion and gray-scale images wi thout  cues for depth 
perception. Intravascular ul trasonography has the 
unique ability to evaluate aneurysm diameter, wall 
thickness, and morphologic  characteristics ~2'13 but  
has not  been shown to be useful dur ing endoluminal  
device expansion and fixation when the accuracy of  
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Table II I .  Prospective comparison of 
fluoroscopic and aortoscopic guidance for Palmaz 
P308 stent placement 
Fluoroscopic guidance Aortoscopic guidance 
(group A; n = 10pigs) (group B; n = 10 pigs) 
DPE~n ....... py (mm) DPE ........ py (ram) 
+2 +2 
+7 +3 
+5 0 
+5 0 
+5 0 
0 -2 
0 0 
-2 +1 
+2 0 
+6 +3 
Mean DPE~I ....... py 3.4 + 2.5 mm 
(p = 0.019) 
Mean DP]Eaortoscopy 1.1+ 1.3 mm 
DPE, Device placement error as depicted in Fig. 3. 
device placement is most important. Aortoscopy has 
been used for guidance of endoluminal ortic proce- 
dures in animals and after endoluminal graft place- 
ment in one patient) °'n Aortoscopy provides real- 
time, full-color images of the endoluminal aortic 
surface and intraaortic devices as they are being 
manipulated, positioned, expanded, and fixed in 
place. 
Potential disadvantages and complications ofaor- 
toscopy include balloon rupture with fragment em- 
bolization, requirement for proximal arterial access, 
increased aortic occlusion time, and increased risk of 
atheromatous and mural thrombus embolization. 
Balloon rupture occurred frequently during our ini- 
tial feasibility study, and the development of a safe 
balloon design became an engineering challenge. 
Simple balloon rupture is of little consequence as long 
as the balloon latex does not fragment. The balloon 
catheter is separate from the angioscope, is inexpen- 
sive, and can be easily replaced. Balloon fragmenta- 
tion can be serious, if latex particles embolize to 
important distal arteries. To make the balloon safe, 
the design has changed to incorporate a "nipple" at 
the distal balloon tip/br reinforcement and to thicken 
the balloon latex for increased overall strength. The 
extra thickness makes a tear in the balloon less likely, 
and the "nipple" helps to hold the balloon together in 
case of rupture. We have not experienced balloon 
fragmentation after rupture with the new design 
changes. 
Aortoseopy requires proximal arterial access and 
specialized training for the surgeon to gain confidence 
and expertise with the technique. The need for 
proximal access is a concern but not one that we 
believe maizes this technique prohibitive. Our present 
system requires akink-resistant 9F introducer sheath. 
In most patients this sheath can be percutaneously 
placed either in a left brachial or axillary artery or by 
open exposure. Because the introducer is large com- 
pared with the artery, close postoperative observation 
is necessary to detect any arterial compromise early so 
that prompt surgical repair can be performed.la Open 
access may be the safest approach and may decrease 
the risk of arterial wall injury and the potential for a 
brachial plexopathy from an axillary hematoma. Most 
modern operating rooms have the necessary video 
equipment and light source required for aortoscopy. 
The only additional equipment requirements are the 
aortoscope components that include the angioscope, 
balloon-tipped catheter, and one-way valve. A 45-cm 
kink-resistant introducer will suffice for introducing 
the aortoscope into the descending thoracic aorta. 
Aortic occlusion by the balloon during aorto- 
scopic visualization may cause renal ischemia, visceral 
ischemia, or both depending on the position of the 
balloon. The ischemia time should be minimized, 
however, because the balloon is insufflated only 
briefly for visualization at no longer than 5-minute 
intervals. Furthermore the balloon can be positioned 
distal to the renal arteries to ensure adequate r nal and 
visceral perfusion, if aortic occlusion is used for 
vascular control as in the case of a ruptured aneurysm. 
The risk of atheromatous and mural thrombus em- 
bolization should be small, if care is taken to always 
deflate the balloon before moving the aortoscope to 
minimize traction forces on the endoluminal aortic 
surface. 
A problem that we often experience during aor- 
toscopic guidcd device placement is that of "fighting 
balloons" (Fig. 4). This term refers to the situation 
encountered when the aortoscope is viewing a device 
such as a stent or graft that is loaded on a typical 
tapered eployment balloon for placement inside the 
aorta. As the deployment balloon is inflated, the 
aortoscope balloon is pushed to one side, away from 
the center of thc aortic lumen. This makcs visualiza- 
tion of the stent or graft morc difficult during its 
actual expansion and fixation in the aorta. Such was 
the case with the Palmaz stents and polytetrafluoro- 
ethylene-Palmaz stcnt grafts that we used in our 
studies. The Corvita graft, on the other hand, did not 
present his problem because of its self-expanding 
properties. The fact that nothing protrudes beyond 
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the end of the Corvita graft is ideal, because it 
facilitates placing the aortoscope against he proximal 
end of the graft as it expands. Thus with the "zero- 
t ip" design of  the Corvita graft, split-second changes 
in the grat~E's position were possible during the graft 
expansion so that the proximal end could be fixed in 
place exactly where it was intended. Although the 
aortoscope seems to be especially well suited and 
complementary to self-expanding, "zero-t ip" de- 
vices, it can still provide guidance for the accurate 
placement of balloon expandable devices as well. 
Unfortunately, aortoscopy does not solve the 
problem with endoluminal pullback measurements, 
because the measuring catheter still takes the long 
outside curve. This problem likely accotmts for the 
tendency for the aortoscopic measurement to be 
slightly less than the "true"  direct postmortem ea- 
surement as shown in Table II. The problem with 
pullback measurements may be more significant in 
humans, in whom aortic diameters are larger than in 
the pig model. 
Advantages of aortoscopy include the improved 
accuracy of device deployment, ability to identify and 
cannulate small branching arteries, ability to inspect 
grafts from the inside after device placement, and 
proximal vascular control when the aortoscope 
balloon is insufflated and aortic blood flow is oc- 
cluded. This form of endoluminal aortic vascular 
control with a balloon, as described by Hyde and 
Sullivan, t4 can establish hemodynamic stability in 
cases of ruptured abdominal aortic aneurysms, may 
decrease blood loss in such cases, and may assist in 
device placement by removing the pulsatile pres- 
sure exerted on the device during each consecu- 
tive cardiac cycle before the device is fixated in the 
aorta. Other advantages of aortoscopy include no 
problem with parallax as encountered with fluoros- 
copy, no requirement for radiation exposure to the 
patient, the surgeon, or operating room personnel, 
and no requirement for contrast media that can 
cause allergic reactions and renal failure in some 
patients. 
The future direction of this new guidance modal- 
ity remains to be seen. I f  aortoscopy proves to have 
significant clinical advantages that outweigh its draw- 
backs, the technique will become helpful to the 
endovascular surgeon. Aortoscopy may prove to be 
particularly useful for guiding the use of devices in the 
aorta. Because of its ability to rapidly provide proximal 
aortic vascular control, aortoscopy may also have a 
beneficial role in treating ruptured abdominal aortic 
aneurysms, if and when the "ideal" endoluminal 
aortic graft system is developed. 
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and Intramed Laboratories, Inc. for providing funding, 
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copy, the Johnson & Johnson Interventional Systems Co. 
for supplying Palmaz stents, the Corvita Corporation and 
Endomed Incorporated for supplying grafts, Meadox 
Surgimed for providing Olbert angioplasty balloon cath- 
eters, Boston Scientific Corporation for supplying angio- 
plasty catheters, and the University of Kentucky Catheter- 
ization Laboratory for supplying catheters and other mate- 
rials for this study. 
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DISCUSSION 
Dr. Calvin B. Ernst (Detroit, Mich.). Dr. Hyde and his 
colleagues have modified and adapted an angioscopic device 
so that the inside of the aorta and its various branches can be 
seen. This is an imaging innovation, because all surgeons 
prefer to see things directly rather than indirectly as with 
fluoroscopy. I think this technology holds promise, because 
by use of the aortoscope intraluminal ortic devices can be 
precisely placed more so than with fluoroscopic methods. I 
know I personally have felt a little uncomfortable when 
inserting an endoluminal prosthesis using radiologic tech- 
nology alone. Also, the radiologic technologist, he sur- 
geon, and the patient are all exposed to radiation. 
When inserting an aortic tube graft for aneurysmal 
disease using radiologic methods, the distance between the 
aortic bifurcation or the renal arteries and the aneurysm 
extent must be approximately 10 mm proximally and 15 
mm distally. Recruiting patients into the endovascular tube 
graft study has been restricted by these limits, so perhaps 
with the accuracy of the aortoscope these distances can be 
shortened and thereby increase the candidate pool for such 
treatment. 
As I understand it, and I hope you clarify this, because 
this is what you said in the article, the aortoscope is passed 
antegrade down the aorta. In the pigs I think it was passed 
through the carotid artery. Clearly, if you are going to use it 
in a human, you would probably have to go through the 
axillary or brachial artery. In a W event, the balloon is passed 
antegrade down the aorta, and then it is inflated somewhere 
below the renal arteries. The inflated balloon then is 
withdrawn cephalad to view the aortic lumen and identify 
the ostia of the various aortic branches. This may be all well 
and good in the pig with a normal aorta, but I think it could 
be more complicated in a human with an anenrysm. I can 
visualize that as the inflated balloon being withdrawn 
cephalad fragmented luminal thrombus i displaced into the 
renal arteries. My first question is, to what extent has your 
experience actually been in humans, and have you devised 
an experimental model of aneurysmal disease to test this 
concept? 
You also noted in the article that the balloon has been 
known to rupture. When latex ruptures, it may fragment 
and cause small emboli. I wonder whether you have had any 
of your manufacturers try to develop a different construc- 
tion, for example, using polyethylene, which does not 
fragment, it just tears. 
I am concerned about his "fighting balloon" phenom- 
enon you described. If when deploying the proximal 
fixation device of an aortic graft he protruding deployment 
balloon displaces the aortoscopic balloon and thereby 
obscures the aortic lumen, malpositioning of the graft or the 
stent may result. Accurate distal deployment may also be 
problematic, because you cannot see, the aorta beyond the 
distal fixation device until after the fixation device is already 
expanded and seated into the aorta, and once deployed, 
adjustment is not possible. Consequently I see the greatest 
potential for aortoscopy in precisely placing the proximal 
fixation device. 
You have documented, by this experimental study, that 
intraaortic devices can be precisely placed, but in the human 
access to the aorta should be or probably will be through the 
brachial or axillary arteries. I think it must be emphasized 
that the price for more precise placement using the aorto- 
scope includes axillary artery complications that may be as 
high as 10%. 
In summary, I think that this is an ingenious concept 
that requires further refinement, and you deserve our 
admiration and thanks for developing it. I have one final 
question: what do you see as the future for aortoscopy 
beyond graft or stent placement, and do you anticipate 
other uses? I look forward, as I am sure wc all do, with great 
anticipation to your future studies. 
Dr. Hyde. You have raised a number of very important 
issues. This video demonstrates our first and only human 
experience with aortoscopy and shows the inside of an aortic 
graft that Juan Parodi nserted in 1994, and we are looking 
inside of that graft. The pulsation of the balloon creates a
real problem and blurs the image. Here you see the native 
vessel, and here is the lip of the right renal artery. Here is the 
left renal orifice with regurgitation of backflow. Again the 
pulsation is massive--it goes 5 to 6 cm. 
Our plan is to deliver this through a 9F axillary artery 
cutdown or percutaneously through a9F introducer sheath. 
Jim May in Sidney, Australia, currently uses proximal access 
anyhow through the axillary artery to have a wire for 
stabilization of deployment of devices. 
Fragmentation is a possibility. There have been millions 
of Fogarty catheters passed, and they do rarely tear and 
embolize. We have not had any fragmentation a d embo- 
lization that we are aware of. 
Other uses being investigated are to direct dilation or 
penetration of grafts or devices covering orifices of aortic 
visceral arteries and to visualize direct athcrectomy of 
orificial esions. 
